NEW YORK, March 13, 2020 /PRNewswire/ -- Today, the American Journal of Kidney Diseases (AJKD) published the National Kidney Foundation's KDOQI Clinical Practice Guideline for Vascular Access: 2019 ...

New York, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vascular Access Devices for Hemodialysis (Nephrology and Urology Devices) - Global Market Analysis and ...

Dallas, TX - Commenting on a study using endothelial progenitor (EP) cells to create an endothelial lining for artificial arteriovenous grafts [ 1], an editorialist suggests that hemodialysis vascular ...

Patients with Medicare, Medicaid more likely to use arteriovenous fistula, graft by fourth dialysis month. (HealthDay News) — Patients with Medicare or Medicaid are more likely than uninsured patients ...

Proteon Therapeutics announced results from a Phase 2 clinical trial of PRT-201 to use to prolong the patency and reduce the failure of hemodialysis vascular access in patients with chronic kidney ...

Despite declining rates of vascular access complications in the United States, Black patients remain at higher risk for them compared with White patients. Despite declining rates of vascular access ...

Most dialysis patients in Canada are prescribed vitamin D analogs orally, while most U.S. dialysis patients are given it intravenously. However, since a practice change in one large U.S. dialysis ...

Please provide your email address to receive an email when new articles are posted on . Hispanic patients were 64% less likely to receive pre-dialysis nephrology care vs. non-Hispanic white patients.

Vital Access has secured a $10 million credit facility from Deerfield Management to expand marketing of its FDA-cleared implant to make it easier to access the vascular system of end-stage renal ...

Despite all the progress achieved since Scribner first introduced the arteriovenous (AV) shunt in 1960 and Cimino and Brescia introduced the native AV fistula in 1962, we have continued to face a ...

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Avenu Medical, Inc. announced today that it has received De Novo marketing authorization from the Food and Drug Administration (FDA) to market its ...